glp-1 trump deal unveils to expand coverage and lower costs on obesity drugs GLP-1 price reduction: President Trump

Ipamorelin activates GHSR-1a (ghrelin receptors) via the PLC/IP3 pathway

Placebo-controlled clinical trials of topical GHK-Cu have documented reductions in fine lines, improvements in skin laxity, and increased keratinocyte proliferation over 12-week protocols

You also lose a little muscle along the way

Advanced Protocol (Experienced Users) Daily Dose : 2-2.5 mg subcutaneous injection (0.025 mg/kg body weight) Timing : Split dosing morning and evening Frequency : Daily for intensive cycles Duration : 6-8 weeks with careful monitoring Advanced dosing should only be attempted by experienced users who have established tolerance

In other words, evidence from a few studies suggests that GLP-1-agonist-induced weight loss may lead to expected levels of muscle loss while improving muscle quality, but further research is needed